Literature DB >> 22136798

Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: brief report and review of the literature.

Mariam M Alhilli1, Harry J Long, Karl C Podratz, Jamie N Bakkum-Gamez.   

Abstract

Granulosa cell tumors are ovarian sex cord stromal cancers that are unique for their indolent nature and late recurrence. Standard treatment regimens utilized include surgery, chemotherapy, and radiotherapy. However, hormonal suppression with aromatase inhibitors, which have shown promising results, may be a viable alternative to these modalities. We present a heavily pre-treated, multi-operated patient who experienced significant tumor shrinkage following treatment with an aromatase inhibitor for her recurrent granulosa cell tumor.
© 2011 The Authors. Journal of Obstetrics and Gynaecology Research © 2011 Japan Society of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136798     DOI: 10.1111/j.1447-0756.2011.01698.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  9 in total

1.  YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors.

Authors:  David Fu; Xiangmin Lv; Guohua Hua; Chunbo He; Jixin Dong; Subodh M Lele; David Wan-Cheng Li; Qiongli Zhai; John S Davis; Cheng Wang
Journal:  Endocr Relat Cancer       Date:  2014-03-04       Impact factor: 5.678

Review 2.  Response to Systemic Therapies in Ovarian Adult Granulosa Cell Tumors: A Literature Review.

Authors:  Geertruid J Brink; Jolijn W Groeneweg; Lotty Hooft; Ronald P Zweemer; Petronella O Witteveen
Journal:  Cancers (Basel)       Date:  2022-06-17       Impact factor: 6.575

Review 3.  Hormonal treatment in recurrent and metastatic gynaecological cancers: a review of the current literature.

Authors:  Dirkje W Sommeijer; Katrin M Sjoquist; Michael Friedlander
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

Review 4.  Presentation of two patients with malignant granulosa cell tumors, with a review of the literature.

Authors:  Ryousuke Tamura; Yoshihito Yokoyama; Takeshi Yanagita; Yukiko Matsumura; Kazuhiro Abe; Ryousuke Taniguchi; Hideki Mizunuma
Journal:  World J Surg Oncol       Date:  2012-09-11       Impact factor: 2.754

Review 5.  Recent advances in granulosa cell tumor ovary: a review.

Authors:  Vijaykumar Dehannathparambil Kottarathil; Michelle Aline Antony; Indu R Nair; Keechilat Pavithran
Journal:  Indian J Surg Oncol       Date:  2012-12-07

6.  Anti-VEGFA Therapy Reduces Tumor Growth and Extends Survival in a Murine Model of Ovarian Granulosa Cell Tumor.

Authors:  Mayra Tsoi; Marie-Noëlle Laguë; Alexandre Boyer; Marilène Paquet; Marie-Ève Nadeau; Derek Boerboom
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

7.  Novel aromatase inhibitors by structure-guided design.

Authors:  Debashis Ghosh; Jessica Lo; Daniel Morton; Damien Valette; Jingle Xi; Jennifer Griswold; Susan Hubbell; Chinaza Egbuta; Wenhua Jiang; Jing An; Huw M L Davies
Journal:  J Med Chem       Date:  2012-09-24       Impact factor: 7.446

Review 8.  The structural biology of oestrogen metabolism.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  J Steroid Biochem Mol Biol       Date:  2013-01-04       Impact factor: 4.292

9.  The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors.

Authors:  Lena Secky; Martin Svoboda; Lukas Klameth; Erika Bajna; Gerhard Hamilton; Robert Zeillinger; Walter Jäger; Theresia Thalhammer
Journal:  J Drug Deliv       Date:  2013-02-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.